Ahsan Habib

Dr. Ahsan Habib

National Council for Air and Stream Improvement, Inc (NCASI), Newberry, Florida, USA
orcid
Analytical Research Scientist | ~ PFAS Researcher | Method D...

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2024 in Applied Catalysis B: Environment and Energy
Verified
Journal Article
Closed access
SYSheng Yin
Sheng Yin
JLJuan Francisco López
Juan Francisco López
Christian Sandoval-PaukerChristian Sandoval-Pauker
Christian Sandoval-Pauker
JSJonathan J. Calvillo Solís
Jonathan J. Calvillo Solís
SGSarah Glass
Sarah Glass
DVDino Villagrán
Dino Villagrán


25 November 2025 in Pollutants
Verified
Journal Article
Open access
PDF file
MAMohammad Jahirul Alam
Mohammad Jahirul Alam
Ahsan HabibAhsan Habib
Ahsan Habib
MAMohammad Jahirul Alam
Mohammad Jahirul Alam
SISaiful Islam
Saiful Islam
EHErshad Halim
Ershad Halim
Poly- and perfluoroalkyl substances (PFASs) are persistent environmental pollutants widely used in industrial applications due to their thermal stability and chemical resistance. However, their persistence in the environment and potential health risks, including developmental and immunological issues, have raised significant concerns. This review highlights the industrial uses, environmental fate, and bioaccumulation of PFASs, emphasizing their widespread presence in air, water, soil, and biota. Major sources of PFAS contamination include industrial discharges, wastewater treatment, and military sites. The atmospheric transport of PFASs contributes to their deposition in remote ecosystems, while aquatic and soil contamination stems from both point and nonpoint sources. Bioaccumulation studies reveal that PFASs accumulate in organisms, leading to potential human exposure through food, water, and consumer products. This review calls for further research to address knowledge gaps in PFAS detection, behavior, and health impacts, while advocating for improved regulations to limit their release and exposure.

28 April 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
SEStephanie Vargas Esquivel
Stephanie Vargas Esquivel
HBHimanshu N. Bhatt
Himanshu N. Bhatt
RDRimpy Diwan
Rimpy Diwan
Ahsan HabibAhsan Habib
Ahsan Habib
WLWen-Yee Lee
Wen-Yee Lee
MNMd Nurunnabi
Md Nurunnabi
The oral route is considered the most convenient route of drug administration for both systemic and local delivery. Besides stability and transportation, another unmet but important issue regarding oral medication is retention duration within the specific region of the gastrointestinal (GI) tract. We hypothesize that an oral vehicle that can adhere and maintain retention within the stomach for a longer duration can be more effective to treat stomach-related diseases. Therefore, in this project, we developed a carrier that is highly specific to the stomach and maintains its retention for a longer duration. We developed a vehicle composed of β-Glucan And Docosahexaenoic Acid (GADA) to observe its affinity and specificity to the stomach. GADA forms a spherical-shaped particle with negative zeta potential values that vary based on the feed ratio of docosahexaenoic acid. Docosahexaenoic acid is an omega-3 fatty acid that has transporters and receptors throughout the GI tract, such as CD36, plasma membrane-associated fatty acid-binding protein (FABP (pm)), and a family of fatty acid transport proteins (FATP1-6). The in vitro studies and characterization data showed that GADA has the capability to carry a payload of hydrophobic molecules and specifically deliver the payload to the GI tract, exert its therapeutic effects, and help to maintain stability for more than 12 h in the gastric and intestinal fluid. The particle size and surface plasmon resonance (SPR) data showed that GADA has a strong binding affinity with mucin in the presence of simulated gastric fluids. We observed a comparatively higher drug release of lidocaine in gastric juice than that in intestinal fluids, demonstrating the influence of the pH values of the media on drug-release kinetics. In vivo and ex vivo imaging of mice demonstrated that GADA maintains its retention within the stomach for at least 4 hr. This stomach-specific oral vehicle holds strong promise to translate various injectable therapeutic drugs to oral form upon further optimizations.

13 October 2024 in Metabolites
Verified
Journal Article
Open access
PDF file
KHKiana Holbrook
Kiana Holbrook
GQGeorge Ekow Quaye
George Ekow Quaye
ELElizabeth Noriega Landa
Elizabeth Noriega Landa
XSXiaogang Su
Xiaogang Su
QGQin Gao
Qin Gao
WLWen-Yee Lee
Wen-Yee Lee
Background: Clear cell renal cell carcinoma (ccRCC) comprises the majority, approximately 70–80%, of renal cancer cases and often remains asymptomatic until incidentally detected during unrelated abdominal imaging or at advanced stages. Currently, standardized screening tests for renal cancer are lacking, which presents challenges in disease management and improving patient outcomes. This study aimed to identify ccRCC-specific volatile organic compounds (VOCs) in the urine of ccRCC-positive patients and develop a urinary VOC-based diagnostic model. Methods: This study involved 233 pretreatment ccRCC patients and 43 healthy individuals. VOC analysis utilized stir-bar sorptive extraction coupled with thermal desorption gas chromatography/mass spectrometry (SBSE-TD-GC/MS). A ccRCC diagnostic model was established via logistic regression, trained on 163 ccRCC cases versus 31 controls, and validated with 70 ccRCC cases versus 12 controls, resulting in a ccRCC diagnostic model involving 24 VOC markers. Results: The findings demonstrated promising diagnostic efficacy, with an Area Under the Curve (AUC) of 0.94, 86% sensitivity, and 92% specificity. Conclusions: This study highlights the feasibility of using urine as a reliable biospecimen for identifying VOC biomarkers in ccRCC. While further validation in larger cohorts is necessary, this study’s capability to differentiate between ccRCC and control groups, despite sample size limitations, holds significant promise.

26 April 2024 in Colloids and Surfaces A: Physicochemical and Engineering Aspects
Verified
Journal Article
Closed access
YGYohannes Getahun
Yohannes Getahun
Ahsan HabibAhsan Habib
Ahsan Habib
VEValeria Erives-Sedano
Valeria Erives-Sedano
WLWen-Yee Lee
Wen-Yee Lee
WPWilson Poon
Wilson Poon
AEAhmed A. El-Gendy
Ahmed A. El-Gendy